Clinical Trials Browser

Phase NA × Carcinoma, Hepatocellular × Infusions, Intravenous × Clear all

NCT07243691 2025-11-24

Study on the Therapeutic Effect of Different Infusion Times of Tislelizumab on Postoperative High-risk Hepatocellular Carcinoma

Phase NA Recruiting

Gastrointestinal

Carcinoma, Hepatocellular